These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29447353)

  • 1. Association of strategic management with vaccination in the terms of globalization.
    Rabrenovic M; Cukanovic Karavidic M; Stosic I
    Int J Qual Health Care; 2018 Apr; 30(3):234-239. PubMed ID: 29447353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives.
    Dellepiane N; Wood D
    Vaccine; 2015 Jan; 33(1):52-61. PubMed ID: 24300593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
    Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
    Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations from the Strategic Advisory Group of Experts to the Department of Immunization, Vaccines and Biologicals.
    Wkly Epidemiol Rec; 2005 Jan; 80(2):11-8. PubMed ID: 15685865
    [No Abstract]   [Full Text] [Related]  

  • 8. Pertussis vaccines: WHO position paper, August 2015--Recommendations.
    WHO
    Vaccine; 2016 Mar; 34(12):1423-5. PubMed ID: 26562318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current costs & projected financial needs of India's Universal Immunization Programme.
    Chatterjee S; Pant M; Haldar P; Aggarwal MK; Laxminarayan R
    Indian J Med Res; 2016 Jun; 143(6):801-808. PubMed ID: 27748306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efforts to monitor Global progress on individual and community demand for immunization: Development of definitions and indicators for the Global Vaccine Action Plan Strategic Objective 2.
    Hickler B; MacDonald NE; Senouci K; Schuh HB; ;
    Vaccine; 2017 Jun; 35(28):3515-3519. PubMed ID: 28536028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting of the Strategic Advisory Group of Experts on immunization, April 2016 – conclusions and recommendations.
    Wkly Epidemiol Rec; 2016 May; 91(21):266-84. PubMed ID: 27236869
    [No Abstract]   [Full Text] [Related]  

  • 14. Crossing the divide from vaccine technology to vaccine delivery. The critical role of providers.
    Orenstein WA; Bernier RH
    JAMA; 1994 Oct; 272(14):1138-9. PubMed ID: 7933328
    [No Abstract]   [Full Text] [Related]  

  • 15. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
    Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
    Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actual immunization coverage throughout Europe: are existing data sufficient?
    Lopalco PL; Carrillo Santisteve P
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():7-11. PubMed ID: 24283205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective vaccine management and Oman's healthcare system's challenge to maintain high global standards.
    Al-Abri SS; Al-Rawahi B; Abdelhady D; Al-Abaidani I
    J Infect Public Health; 2018; 11(5):742-744. PubMed ID: 29779847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme.
    Kaljee LM; Pack R; Pach A; Nyamete A; Stanton BF
    J Health Popul Nutr; 2004 Sep; 22(3):293-303. PubMed ID: 15609782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress report on the National Immunization Strategy.
    Kondro W
    CMAJ; 2007 Jun; 176(13):1811-3. PubMed ID: 17576972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.